Conjugates targeted to the interleukin-2 receptor
AssigneeWatson Pharmaceuticals, Inc.
InventorsRamesh K. Prakash, Christopher M. Clemens
Life of this patent
Estimating the term…
Loading patent…
AssigneeWatson Pharmaceuticals, Inc.
InventorsRamesh K. Prakash, Christopher M. Clemens
Estimating the term…
A composition for intracellular delivery of a chemical agent into an interleukin-2-receptor-bearing cell, e.g. an activated T cell, includes a chemical agent and at least one copy of an interleukin-2-receptor-binding and endocytosis-inducing ligand coupled to a water soluble polymer. The ligand binds to a receptor on the interleukin-2-receptor-bearing cell and elicits endocytosis of the composition. The composition also preferably includes a spacer for coupling the chemical agent and the ligand to the polymer. Chemical agents can include cytotoxins, transforming nucleic acids, gene regulators, labels, antigens, drugs, and the like. A preferred water soluble polymer is a polyalkylene oxide, such as polyethlene glycol and polyethylene oxide, and activated derivatives thereof. The composition can further comprise a carrier such as another water soluble polymer, liposome, or particulate. Methods of using these compositions for delivering a chemical agent in vivo or in vitro are also disclosed. A method of detecting a disease, such as T-cell lymphocytic leukemia, T-cell acute lymphoblastic leukemia, peripheral T-cell lymphoma, Hodgkin's disease, or non-Hodgkin's lymphoma, associated with elevated levels of soluble IL-2 receptor is also disclosed.
A method of delivering a chemical agent in vitro into a IL-2-receptor-bearing cell in a population of cells, comprising the steps of:
A method of delivering a chemical agent into an IL-2-receptor-bearing cell in a warm-blooded animal, comprising the steps of:
Dependencies are inferred from the claim text.